Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
Journal of Public Health in Africa
| Field | Value | |
| Title | Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria | |
| Creator | Eguavoen, Amenze Larson, Heidi J. Chinye-Nwoko, Fejiro Ojeniyi, Toluwanimi | |
| Description | By May 30, 2022, there were 526,182,662 confirmed COVID-19 cases and 6,286,057 deaths globally; of which Nigeria had recorded 256,028 confirmed cases and 3143 deaths. By the same time, Nigeria had received a total of 93.9 million doses of the COVID-19 vaccine, enough to vaccinate 25% of the population; however, only 27.4 million people (13.3% of the population) had received at least one dose of the vaccine. This article examines available evidence on COVID-19 vaccine hesitancy in Nigeria and makes recommendations for improving its uptake. Major causes of COVID-19 vaccine hesitancy identified in Nigeria were concerns around vaccine efficacy and safety, disbelief in the existence and severity of the disease, and distrust of the government. To reduce COVID-19 vaccine hesitancy and improve vaccine coverage in Nigeria, mapping vaccine acceptance and hesitancy across geographies and demographics is needed, as well as increased stakeholder communication, and effective community engagement. | |
| Publisher | AOSIS | |
| Date | 2023-05-31 | |
| Identifier | 10.4081/jphia.2023.2290 | |
| Source | Journal of Public Health in Africa; Vol 14, No 5 (2023); 5 2038-9930 2038-9922 | |
| Language | eng | |
| Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://publichealthinafrica.org/index.php/jphia/article/view/213/262
|
|
ADVERTISEMENT
